Belvedere Trading
TMDX icon

Belvedere Trading’s Transmedics TMDX Stock Holding History

Belvedere Trading’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-18,821
Closed -$781K – 440
2021
Q1 		$781K Buy
18,821
+6,200
+49% +$191K 0.06% 65
2020
Q4 		$251K Buy
+12,621
New +$187K 0.01% 125

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Belvedere Trading's TMDX Position: Q2 2021 in Review

Belvedere Trading sold out of Transmedics (TMDX) in Q2 2021, closing a stake of 18,821 shares — an estimated $781K sold.

Belvedere Trading first reported a position in TMDX in Q4 2020 and held it in 2 quarters. The position peaked at $781K in Q1 2021. 124 funds tracked by Wall St. Rank hold TMDX as of Q2 2021.

  • Belvedere Trading reported no remaining Transmedics position as of Q2 2021 after selling out during the quarter.
  • Belvedere Trading sold 18,821 Transmedics shares in Q2 2021, an estimated $781K.
  • Belvedere Trading first reported a position in Transmedics in Q4 2020 and held it in 2 quarters.
  • Belvedere Trading's Transmedics position peaked at $781K in Q1 2021.
  • 124 funds tracked by Wall St. Rank held Transmedics as of Q2 2021.

Based on Belvedere Trading's 13F filing for Q2 2021, filed 23 Jul 2021.